v3.26.1
Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Preferred Stock [Member]
A P I C Preferred [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stocks [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2024 $ 1,809 $ 45,101,675 $ (50,608,445) $ (5,504,961)
Beginning balance, shares at Dec. 31, 2024     18,090,526        
Sale of common stock, net of offering costs     $ 73 10,252,425   10,252,498
Sale of common stock, net of offering costs, shares     727,750        
Common stock issued for advisory services     $ 5 557,055   557,060
Common stock issued for advisory services, shares     46,000        
Cashless exercise of warrants     $ 16 (16)  
Cashless exercise of warrants, shares     162,500        
Stock based compensation     17,397,774   17,397,774
Net loss (32,326,016) (32,326,016)
Ending balance, value at Mar. 31, 2025 $ 1,903 73,308,913 (82,934,461) (9,623,645)
Ending balance, shares at Mar. 31, 2025     19,026,776        
Stock based compensation     3,526,076   3,526,076
Other       (37,755)   (37,755)
Net loss (5,680,170) (5,680,170)
Ending balance, value at Jun. 30, 2025 $ 1,903 76,797,234 (88,614,631) (11,815,494)
Ending balance, shares at Jun. 30, 2025     19,026,776        
Beginning balance, value at Dec. 31, 2025 $ 2,198 97,951,035 $ (2,706,307) (112,754,655) (17,507,729)
Beginning balance, shares at Dec. 31, 2025   21,990,688   302,766    
Common stock issued for advisory services $ 1 (1)
Common stock issued for advisory services, shares     5,000        
Restricted share grants released from restriction $ 94 (94)
Restricted share grants released from restriction, shares     937,347        
Common stock issued for equity line of credit $ 8 663,719 663,727
Common stock issued for equity line of credit, shares     76,648        
Common stock issued for private placement $ 182 7,814,463 7,814,645
Common stock issued for private placement, shares     1,815,528        
Warrants issued for private placement 5,257,138 5,257,138
Stock based compensation 2,732,398 2,732,398
Tax effect related to net share settlement of equity awards $ (3,371,412) (3,371,412)
Tax effect related to net share settlement of equity awards, shares         394,204    
Net loss (8,819,932) (8,819,932)
Ending balance, value at Mar. 31, 2026 $ 2,483 114,418,658 $ (6,077,719) (121,574,587) (13,231,165)
Ending balance, shares at Mar. 31, 2026   24,825,211   696,970    
Series A preferred shares issued, net of derivative allocation and issuance costs $ 1 3,134,003 3,134,004
Series A preferred shares issued, net of derivative allocation and issuance costs, shares 6,000            
Restricted share grants released from restriction $ 83 (83)
Restricted share grants released from restriction, shares     830,377        
Common stock issued for private placement $ 28 1,179,243 1,179,271
Common stock issued for private placement, shares     277,777        
Warrants issued for private placement 820,729 820,729
Stock based compensation 5,651,913 5,651,913
Tax effect related to net share settlement of equity awards $ (1,844,019) (1,844,019)
Tax effect related to net share settlement of equity awards, shares         382,573    
Net loss (14,240,044) (14,240,044)
Ending balance, value at Jun. 30, 2026 $ 1 $ 3,134,003 $ 2,594 $ 122,070,460 $ (7,921,738) $ (135,814,631) $ (18,529,311)
Ending balance, shares at Jun. 30, 2026 6,000   25,933,365   1,079,543